MedPath

Yoga Efficacy and Bioactive Materials in the Blood of Korean Elderly

Not Applicable
Conditions
Healthy Elderly
Yoga
Registration Number
NCT03691129
Lead Sponsor
Wonryeon Cho
Brief Summary

This study is conducted to verify the relationships between yoga efficacy and bioactive materials in the blood of Korean elderly.

Detailed Description

Glycoproteomics approach will be applied to verify the relationships between yoga efficacy and bioactive materials in the blood of Korean elderly.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • The elderly group participant over 60 years old.
  • The young group participant over 20 to 57 years old.
  • Individual who can read and understand Korean.
  • Participant is willing and able to give informed consent for participation in the study.
Exclusion Criteria
  • Participant who was diagnosed with cancer in the last five years.
  • In case of participants leaving the yoga program after the primary blood collecting, they will be excluded from the secondary blood collecting.
  • Individuals who are judged inappropriate for the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Measuring the number of glycoproteins in blood between before and after participation in an elderly yoga program for both the Advanced group and Beginner group4 months

Glycoproteins in human plasma are known to be deeply associated with multiple diseases, cell differentiation, aging, and etc.

The efficacy of elderly yoga will be assessed by identifying and comparing the number of glycoproteins in blood between before and after participation in an elderly yoga program for both the Advanced group and Beginner group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wonkwang University

🇰🇷

Iksan, Jeonbuk, Korea, Republic of

Wonkwang University
🇰🇷Iksan, Jeonbuk, Korea, Republic of
Wonryeon Cho
Contact
wcho@wku.ac.kr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.